Skip to main content
2023 ACVIM Forum Main banner
Final Program


2023 Event Program
Icon Legend
This session is not on your agenda.
This session is on your agenda. Click again to remove it.
Presentation Icons
ACVIM Resident Research Award Eligible
ACVIM Resident Research Award Eligible
Additional Fees May Be Required
Additional Fees May Be Required
By Invite Only
By Invite Only
Capturing for On Demand
Capturing for On Demand
Cardiology Research Abstract Award Eligible
Cardiology Research Abstract Award Eligible
ERC Approved Lecture for ACVIM Residency
ERC Approved Lecture for ACVIM Residency
ePoster
ePoster
Livestream
Livestream
One Health
One Health
Pre-Registration Required
Pre-Registration Required
RACE-Approved
RACE-Approved
Research Abstract
Research Abstract
Specialty Symposium
Specialty Symposium
State-of-the-Art (SOTA) Presentation
State-of-the-Art (SOTA) Presentation
Veterinary Technician
Veterinary Technician
Back
Evaluation ViewAttendees 7

Small Animal Internal Medicine

Next Generation Nucleic Acid vaccines for the Prevention of Infectious Diseases in Humans and their Pets (Planned by ISCAID)

Saturday, June 17, 2023
8:00 AM – 9:00 AM ET
Location: PCC 111AB
CE: 1
ERC Approved Lecture for ACVIM Residency

The COVID-19 pandemic brought nucleic acid vaccines, including DNA and mRNA vaccines to the forefront and realized their promise in providing a rapid response to emerging infectious diseases. COVID-19 mRNA vaccines shattered records in the amount of time it takes to develop an effective vaccine against a new pandemic. While seemingly new, these vaccines actually got their start over 30 years ago with a grand vision for not only stopping a pandemic but to also protect against many other pathogens and diseases. This session will review the history of how nucleic acid vaccines got their start, what we know to date about how they work, how they differ from traditional vaccines and future strategies that could make these vaccines a game changer to protect humans and their pets from other infectious diseases and to treat chronic diseases and cancer.

Learning Objectives:

  • List 3 pathogens that infect both humans and their pets
  • Describe 3 key advantages of mRNA and DNA vaccines for veterinary vaccines
  • Explain why dogs and humans are highly susceptible to infection with Coccidioidomycosis and why a nucleic acid vaccine could be an effective strategy to protect from this disease.